Innate Pharma
IPHA
#8292
Rank
C$0.24 B
Marketcap
$2.94
Share price
-5.09%
Change (1 day)
-14.60%
Change (1 year)

Earnings for Innate Pharma (IPHA)

Earnings in 2022: -C$89.3 Million

According to Innate Pharma 's latest financial reports the company's current earnings are C$53.18 Million. In 2022 the company made an earning of -C$89.3 Million a decrease over its 2021 earnings that were of -C$73.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innate Pharma from 2005 to 2022

Annual earnings

Year Earnings Change
2022-C$89.3 Million20.74%
2021-C$73.96 Million4951.09%
2020-C$1.47 Million-111.57%
2019C$12.65 M183.46%
2018C$4.46 M-105.4%
2017-C$82.73 Million-523.25%
2016C$19.54 M-285.64%
2015-C$10.53 Million-69.31%
2014-C$34.32 Million498.29%
2013-C$5.74 Million-5.62%
2012-C$6.08 Million-53.32%
2011-C$13.02 Million-50.1%
2010-C$26.09 Million-13.3%
2009-C$30.09 Million26.36%
2008-C$23.82 Million27.35%
2007-C$18.7 Million63.33%
2006-C$11.45 Million9.81%
2005-C$10.43 Million